Phase 1 6 trials
Phase 1
NCT05942508 May 2023 → Feb 2026 small cell lung carcinoma Jinming Yu
Unknown
No outcome recorded
Phase 1
NCT06116240 Sep 2022 → Dec 2023 cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1
NCT03897283 Jun 2019 → Jun 2020 cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1
NCT03910127 Jun 2019 → Dec 2020 non-small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1
NCT03855358 May 2019 → Jun 2020 triple-negative breast carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1
NCT03460457 Mar 2018 → Mar 2019 neoplasm Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1/2 9 trials
Phase 1/2
NCT05608785 Jan → Dec 2023 gastric cancer , gastroesophageal cancer Henan Cancer Hospital
Unknown
No outcome recorded
Phase 1/2
NCT05645315 Apr 2022 → Dec 2023 neoplasm Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1/2
NCT05139082 Nov 2021 → Oct 2023 digestive system neoplasm Peking University
Unknown
No outcome recorded
Phase 1/2
NCT04888546 Apr 2021 → Jul 2024 hepatocellular carcinoma Chinese Academy of Medical Sciences
Unknown
No outcome recorded
Phase 1/2
NCT04236362 Feb 2020 → Dec 2021 female reproductive organ cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1/2
NCT03996408 Jun 2019 → Dec 2020 cholangiocarcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1/2
NCT03991975 Jun 2019 → Mar 2020 melanoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1/2
NCT03983928 Jun 2019 → Oct 2020 lung cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1/2
NCT03825705 Apr 2019 → Jan 2021 adenocarcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 2 51 trials
Phase 2
NCT07627464 May 2026 → Dec 2028 expected renal cell carcinoma Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07602101 May 2026 → Dec 2027 expected clear cell renal carcinoma RenJi Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07643350 May 2026 → May 2029 expected non-small cell lung carcinoma The Third Xiangya Hospital of Central South University
Not yet recruiting
No outcome recorded
Phase 2
NCT07510594 May → Dec 2026 expected pulmonary large cell neuroendocrine carcinoma Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07538258 Apr 2026 → Sep 2027 expected small cell lung carcinoma Yayi He
Not yet recruiting
No outcome recorded
Phase 2
NCT07538271 Apr 2026 → Sep 2027 expected small cell lung carcinoma Yayi He
Not yet recruiting
No outcome recorded
Phase 2
NCT07537777 Apr 2026 → Jan 2028 expected hepatocellular carcinoma Nanfang Hospital, Southern Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT07548177 Apr 2026 → Nov 2027 expected alveolar soft part sarcoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT07193186 Apr 2026 → Dec 2029 expected thyroid cancer Fudan University
Not yet recruiting
No outcome recorded
Phase 2
NCT07489300 Mar 2026 → Jan 2027 expected fallopian tube cancer , ovarian cancer , primary peritoneal carcinoma Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
No outcome recorded
Phase 2
NCT07294261 Dec 2025 → Oct 2028 expected non-small cell lung carcinoma Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT07109167 Aug 2025 → Aug 2026 overdue biliary tract neoplasm The Second Affiliated Hospital of Shandong First Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT06953843 Jul 2025 → Jun 2027 expected —
Xinqiao Hospital of Chongqing
Recruiting
No outcome recorded
Phase 2
NCT06848439 Jun 2025 → Dec 2027 expected oral cavity cancer Jiangsu Cancer Institute & Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06978153 May 2025 → Nov 2027 expected small cell lung carcinoma Tang-Du Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06874933 May 2025 → Apr 2027 expected hormone receptor-positive breast cancer First Affiliated Hospital of Zhejiang University
Recruiting
No outcome recorded
Phase 2
NCT06429397 May 2025 → May 2027 expected pheochromocytoma Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT06914297 Apr 2025 → Oct 2027 expected endometrial cancer Fudan University
Recruiting
No outcome recorded
Phase 2
NCT06992336 Apr 2025 → Apr 2031 expected breast cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting
No outcome recorded
Phase 2
NCT06897579 Apr 2025 → Apr 2026 small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Terminated
No outcome recorded
Phase 2
NCT06851169 Apr 2025 → Feb 2027 expected non-small cell lung carcinoma Tang-Du Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06699498 Dec 2024 → Dec 2025 overdue head and neck squamous cell carcinoma The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT06767800 Nov 2024 → Sep 2026 expected gastroesophageal adenocarcinoma Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06621095 Oct 2024 → Dec 2025 overdue malignant pancreatic neoplasm RenJi Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06637163 Oct 2024 → Apr 2026 overdue esophageal squamous cell carcinoma Shanghai Zhongshan Hospital
Recruiting
No outcome recorded
Phase 2
NCT06496490 Aug 2024 → Jun 2026 overdue non-small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06475287 Jul 2024 → Jul 2025 overdue hepatocellular carcinoma Fudan University
Not yet recruiting
No outcome recorded
Phase 2
NCT06528847 Jun 2024 → Jun 2027 expected non-small cell lung carcinoma Shanghai Pulmonary Hospital, Shanghai, China
Recruiting
No outcome recorded
Phase 2
NCT06662006 Mar 2024 → Dec 2027 expected malignant pancreatic neoplasm The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting
No outcome recorded
Phase 2
NCT06222944 Feb 2024 → Aug 2025 overdue gastric cancer , gastroesophageal junction adenocarcinoma Peking University
Not yet recruiting
No outcome recorded
Phase 2
NCT06733051 Jan 2024 → Dec 2026 expected mature T-cell and NK-cell non-Hodgkin lymphoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT06109402 Dec 2023 → Nov 2030 expected non-small cell lung carcinoma Shanghai Pulmonary Hospital, Shanghai, China
Not yet recruiting
No outcome recorded
Phase 2
NCT06031480 Oct 2023 → Oct 2025 hepatocellular carcinoma Shanghai Zhongshan Hospital
Unknown
No outcome recorded
Phase 2
NCT05913089 Jun 2023 → Jun 2026 overdue non-small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06939452 Jun 2023 → Jun 2026 overdue gastroesophageal adenocarcinoma Yongxu Jia
Active not recruiting
No outcome recorded
Phase 2
NCT05812430 Apr → Oct 2023 biliary tract cancer The First Affiliated Hospital of Zhengzhou University
Unknown
No outcome recorded
Phase 2
NCT05582499 Nov 2022 → Dec 2027 expected HER2 positive breast carcinoma , female breast carcinoma , hormone receptor-positive breast cancer , triple-negative breast carcinoma Fudan University
Recruiting
No outcome recorded
Phase 2
NCT05481645 Aug 2022 → Feb 2024 endometrial cancer , uterine corpus sarcoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Terminated
No outcome recorded
Phase 2
NCT05252078 Jun 2022 → Nov 2026 expected esophageal squamous cell carcinoma Jiangxi Provincial Cancer Hospital
Recruiting
No outcome recorded
Phase 2
NCT05038813 Mar 2022 → Mar 2024 esophageal squamous cell carcinoma The First Affiliated Hospital of Zhengzhou University
Unknown
No outcome recorded
Phase 2
NCT05311319 Jan → Dec 2022 hepatocellular carcinoma Fudan University
Unknown
No outcome recorded
Phase 2
NCT05111366 Jan 2022 → Jan 2024 hepatocellular carcinoma Xianhai Mao
Unknown
No outcome recorded
Phase 2
NCT05013697 Sep 2021 → Dec 2022 neoplasm of esophagus Henan Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT04895345 Jun 2021 → Apr 2024 nasopharyngeal carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Completed
No outcome recorded
Phase 2
NCT04623333 Nov 2020 → Dec 2022 —
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 2
NCT04574284 Sep 2020 → Nov 2023 endometrial cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Completed
No outcome recorded
Phase 2
NCT04539977 Sep 2020 → Dec 2023 overdue small cell lung carcinoma Shanghai Pulmonary Hospital, Shanghai, China
Recruiting
No outcome recorded
Phase 2
NCT04306926 Mar 2020 → Oct 2022 non-small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 2
NCT04202653 Jan → Dec 2020 chronic hepatitis B virus infection Tongji Hospital
Unknown
No outcome recorded
Phase 2
NCT04002622 Aug 2019 → Jan 2021 primary mediastinal large B-cell lymphoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Terminated
No outcome recorded
Phase 2
NCT03800706 Mar 2019 → Jun 2021 —
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Show 41 more trials Phase 2/3 1 trial
Phase 2/3
NCT07535567 May 2026 → Dec 2028 expected head and neck squamous cell carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not yet recruiting
No outcome recorded
Phase 3 15 trials
Phase 3
NCT07446335 Apr 2026 → Dec 2028 expected esophageal squamous cell carcinoma The First Affiliated Hospital of Zhengzhou University
Not yet recruiting
No outcome recorded
Phase 3
NCT06955325 May 2025 → Dec 2030 expected non-small cell lung carcinoma The First Affiliated Hospital of Guangzhou Medical University
Not yet recruiting
No outcome recorded
Phase 3
NCT06469879 Sep 2024 → Sep 2026 expected small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT06475599 Jul 2024 → Dec 2027 expected endometrial cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT05922345 Jun 2023 → Aug 2025 non-small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT05718167 Feb 2023 → Oct 2024 non-small cell squamous lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT05346952 Jan 2022 → Dec 2023 non-small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT05145218 Sep 2021 → Oct 2024 —
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT04964479 Aug 2021 → Dec 2022 non-small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT04809142 Feb 2021 → Mar 2022 biliary tract cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT04523272 Aug 2020 → Jun 2025 overdue kidney cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT04405505 Jun 2020 → Jul 2022 triple-negative breast carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT04325763 May 2020 → Dec 2022 non-small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT04234607 Jan 2020 → Dec 2022 small cell lung carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT03855384 Jun 2019 → Dec 2020 head and neck squamous cell carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Show 5 more trials Phase 4 1 trial
Phase 4
NCT06931145 Apr 2025 → Apr 2027 expected small cell lung carcinoma Peking Union Medical College Hospital
Not yet recruiting
No outcome recorded
Phase not applicable 2 trials
— NCT06603974 Oct 2024 → Jul 2026 overdue gastric cancer Xijing Hospital
Not yet recruiting
No outcome recorded
— NCT04891900 May 2021 → Dec 2024 gastric cancer , gastroesophageal junction adenocarcinoma Henan Cancer Hospital
Unknown
No outcome recorded